In recent years, there have been systematic reviews of the cardiovascular effects of incretin-based therapies [13, 25] and their risks of bone fractures [26, 27], respiratory tract infections [28], and pancreatic cancer [29]. The gene discussed is GCG; the disease is Respiratory tract infection.